Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-08

FDA Approved: SOLTAMOX — Supplemental Application (Mayne Pharma)

View source ↗

Summary

The FDA approved a supplemental application for Soltamox (tamoxifen citrate) submitted by Mayne Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SOLTAMOX (Tamoxifen citrate)

Snippet

SUPPL AP for SOLTAMOX (TAMOXIFEN CITRATE)